PRCT - Procept Q3 GAAP EPS of -$0.51
2023-11-01 16:09:07 ET
More on Procept
- Procept BioRobotics: Adding Value Through Robust Unit Economics, Reiterate Buy
- PROCEPT BioRobotics gets FDA okay for prostate cancer study
- Piper Sandler starts Procept at overweight, cites high growth potential
- Seeking Alpha’s Quant Rating on Procept
- Historical earnings data for Procept
For further details see:
Procept Q3 GAAP EPS of -$0.51